Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials

K Sridharan, G Sivaramakrishnan - British journal of clinical …, 2018 - Wiley Online Library
… Also, head-to-head comparison using various growth factors in the management of DFU … is
the first evidence comparing the efficacies and safety of various growth factors, albeit indirectly…

Efficacy and Safety of Anti–Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison

Y Zhang, S Gao, X Li, X Huang, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
efficacy and safety of anti–vascular endothelial growth factor (… randomized controlled trials
comparing the recommended … regimens had better visual efficacy. Brolucizumab had absolute …

Randomized placebo‐controlled and controlled non‐inferiority phase III trials comparing trafermin, a recombinant human fibroblast growth factor 2, and enamel matrix …

M Kitamura, M Akamatsu, M Kawanami… - Journal of Bone and …, 2016 - academic.oup.com
… We investigated the efficacy, safety, and clinical significance of trafermin, a recombinant
human fibroblast growth factor (rhFGF)‐2, for periodontal regeneration in intrabony defects in …

Efficacy and safety of becaplermin (recombinant human platelet‐derived growth factor‐BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined …

JM Smiell, TJ Wieman, DL Steed… - Wound Repair and …, 1999 - Wiley Online Library
… the results of the 4 individual studies to more precisely assess the relative efficacies of 4
treatment regimens, with a focus on the comparison of becaplermin gel at a dose of 100 μg/g vs. …

Comparison of the efficacy of gefitinib in patients with non-small cell lung cancer according to the type of epidermal growth factor receptor mutation

S Igawa, M Kasajima, M Ishihara, M Kimura, Y Hiyoshi… - Oncology, 2014 - karger.com
Background: Exon 19 deletion and L858R point mutation of the epidermal growth factor
receptor (EGFR) are the most commonly encountered EGFR mutations in non-small cell lung …

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously …

S Noda-Narita, A Shimomura, A Kawachi… - Breast Cancer, 2019 - Springer
… for patients with human epidermal growth factor receptor 2 (HER2… efficacy of T-DM1 in those
who have previously received pertuzumab (Pmab). This study aimed to compare the efficacy

Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell …

N Aiko, T Shimokawa, K Miyazaki, Y Misumi, Y Agemi… - BMC cancer, 2018 - Springer
… Compared with standard chemotherapy, epidermal growth factor … However, data comparing
the efficacies of different EGFR−TKIs, … epidermal growth factor receptor (EGFR) mutations [2]. …

Comparisons of Cytokines, Growth Factors and Clinical Efficacy between Platelet-Rich Plasma and Autologous Conditioned Serum for Knee Osteoarthritis …

PG Cheng, KD Yang, LG Huang, CH Wang, WS Ko - Biomolecules, 2023 - mdpi.com
growth factors we performed in the present study may provide the opportunity for subjective
comparisons… the anti-inflammatory mediator and growth factors between both groups. Further …

The efficacy of nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: a meta-analysis

S Yang, Y Huang, Z Ye, L Li, Y Zhang - Frontiers in Pharmacology, 2020 - frontiersin.org
… Background: Nerve growth factor (NGF) plays a crucial role in pain modulation and is being
… The purpose of this meta-analysis was to study the efficacy of anti-NGF antibodies for the …

Efficacy and safety of nerve growth factor for the treatment of neurological diseases: a meta-analysis of 64 randomized controlled trials involving 6,297 patients

M Zhao, X Li, C Xu, L Zou - Neural regeneration research, 2015 - journals.lww.com
growth factor is approved for large-scale use as a clinical medicine. More than 10 years ago,
in 2003, nerve growth factor … controlled trials of nerve growth factor during the past ten years …